TARS smart money
Tarsus Pharmaceuticals INC (TARS): 9 top funds holding it, 3 ETF changes in the public filings.
Top funds added, latest quarter$221M
Top 100 funds holding it
| # | Fund | Change | Weight | Value |
|---|---|---|---|---|
| 10 | Paradigm Biocapital Advisors LP | TRIM -17% | 3.60% | $181M |
| 19 | Tcg Crossover Management, LLC | BUY | 0.86% | $30M |
| 24 | Orbimed Advisors LLC | 0.05% | $3M | |
| 25 | Mpm Bioimpact LLC | ADD +10% | 2.13% | $28M |
| 30 | Deep Track Capital, LP | ADD +4% | 5.04% | $299M |
| 46 | Sofinnova Investments, INC. | BUY | 0.43% | $9M |
| 58 | Bain Capital Life Sciences Investors, LLC | BUY | 5.78% | $86M |
| 63 | Vestal Point Capital, LP | ADD +94% | 4.13% | $160M |
| 86 | Adar1 Capital Management, LLC | BUY | 0.23% | $5M |
ETF changes
| ETF | Change | Value | Report |
|---|---|---|---|
| Invesco Pharmaceuticals ETF | ADD | +$4M | 2026-07-31 |
| State Street(R) Spdr(R) S&p(R) Pharmaceuticals ETF | ADD | +$1M | 2026-06-30 |
| Ishares U.S. Pharmaceuticals ETF | TRIM | −$400k | 2026-06-30 |